Sławomira Kyrcz‐Krzemień

Medical University of Silesia — Poland

Medicine · Health Sciences

31h-index3.6kcitations331works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(83), Chronic Lymphocytic Leukemia Research(82), Hematopoietic Stem Cell Transplantation(73), Acute Lymphoblastic Leukemia research(62), Chronic Myeloid Leukemia Treatments(62)

Publications330 total

Treatment-Free Remission (TFR) after Two Different Durations of Nilotinib Consolidation in Patients with Chronic Myeloid Leukemia (CML) Previously Treated with Imatinib: Enestpath Study Results
Blood·2021· 4 cited
Correction to: Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase: ENESTnd 10-year analysis
Leukemia·2021· 11 citedOpen Access
Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase: ENESTnd 10-year analysis
Leukemia·2021· 335 citedOpen Access
Infectious Complications in Patients With Multiple Myeloma After High-Dose Chemotherapy Followed by Autologous Stem Cell Transplant: Nationwide Study of the Infectious Complications Study Group of the Polish Adult Leukemia Group
Transplantation Proceedings·2020· 20 citedOpen Access
Cereblon (<i>CRBN</i>) gene polymorphisms predict clinical response and progression-free survival in relapsed/refractory multiple myeloma patients treated with lenalidomide: a pharmacogenetic study from the IMMEnSE consortium
Leukemia & lymphoma/Leukemia and lymphoma·2019· 9 citedOpen Access
Enestpath Leukemic Stem Cell (LSC) Sub-Study: Analyzing Characteristics of LSC-Positive Patients and Impact of Switch from Imatinib to Nilotinib Therapy on LSCs in Patients with Chronic Myeloid Leukemia
Blood·2019
Long-Term Outcomes in Patients with Chronic Myeloid Leukemia in Chronic Phase Receiving Frontline Nilotinib Versus Imatinib: Enestnd 10-Year Analysis
Blood·2019· 27 cited
Age-dependent determinants of infectious complications profile in children and adults after hematopoietic cell transplantation: lesson from the nationwide study
Annals of Hematology·2019· 49 citedOpen Access
A phase <scp>III</scp> randomized, multicentre, double blind, active controlled trial to compare the efficacy and safety of two different anagrelide formulations in patients with essential thrombocythaemia – the <scp>TEAM</scp>‐<scp>ET</scp> 2·0 trial
British Journal of Haematology·2019· 6 citedOpen Access
Analysis of Risk Factors Determining Incidence and Outcome of Infections in Children and Adults after Hematopoietic Cell Transplantation
Blood·2018
HLA-inferred extended haplotype disparity level is more relevant than the level of HLA mismatch alone for the patients survival and GvHD in T cell-replate hematopoietic stem cell transplantation from unrelated donor
Human Immunology·2018· 12 citedOpen Access
The Influence of Genetic Variations in the <i>CD86</i> Gene on the Outcome after Allogeneic Hematopoietic Stem Cell Transplantation
Journal of Immunology Research·2018· 5 citedOpen Access
Indolent systemic mastocytosis associated with multiple myeloma: A rare coexistence
Acta Haematologica Polonica·2017· 1 cited
Analysis of mixed population of erythrocytes (chimerism of erythrocytes) by flow cytometry in patients who underwent allogeneic hematopoietic stem cell transplantation
Postępy Nauk Medycznych·2017
Diagnostic difficulties in Ewing sarcoma in an adult male – a case report and review of the literature
Postępy Nauk Medycznych·2017
Long-Term Outcome of Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Acute Myeloid Leukemia (AML)- Single Center Retrospective Analysis
Pathology & Oncology Research·2017· 4 citedOpen Access
Metastasis of solid tumors into bone marrow – Single center experience
Acta Haematologica Polonica·2017· 2 cited
Efficacy and toxicity of compassionate ibrutinib use in relapsed/refractory chronic lymphocytic leukemia in Poland: analysis of the Polish Adult Leukemia Group (PALG)
Leukemia & lymphoma/Leukemia and lymphoma·2017· 39 cited
Resolution of thrombocytopenia, but not polycythemia after ruxolitinib for polycythemia vera with detectable mutation in the exon 12 of the JAK2 gene
Medical Oncology·2017· 1 citedOpen Access
Addition of cladribine to the standard induction treatment improves outcomes in a subset of elderly acute myeloid leukemia patients. Results of a randomized Polish Adult Leukemia Group (PALG) phase II trial
American Journal of Hematology·2017· 26 citedOpen Access
page 1 of 17Next →

Frequent Co-authors

Jerzy Hołowiecki(15), Sebastian Giebel(15), Grzegorz Helbig(14), Mirosław Markiewicz(10), Tadeusz Robak(9), W Wiktor-Jędrzejczak(9), Agnieszka Wierzbowska(9), Sebastian Grosicki(8), Kazimierz Kuliczkowski(7), Krzysztof Warzocha(7), Myriam Labopin(7), Jerzy Wojnar(7), Marek Hus(7), Mohamad Mohty(6), Małgorzata Krawczyk‐Kuliś(6), Monika Dzierżak‐Mietła(6), Andrzej Hellmann(6), Anna Dmoszyńska(5), Mieczysław Komarnicki(5), Dietrich W. Beelen(5)